Cancer Research Communications

23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.

Branched-Chain Amino Acid Catabolism Promotes Ovarian Cancer Cell Proliferation via Phosphorylation of mTOR.

The XPO1 Inhibitor Eltanexor Modulates the Wnt/β-Catenin Signaling Pathway to Reduce Colorectal Cancer Tumorigenesis.

Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients.

Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

利用 Kaede 光转换转基因小鼠动态跟踪肿瘤微环境调节，揭示病毒免疫疗法的新生物学特性

Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials

接受瑞戈非尼治疗的难治性结直肠癌患者的斯钙素 1：TEXCAN 和 CORRECT 试验的事后生物标志物分析

A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain-Liver Metastasis Axis

黑色素瘤脑转移 CTC 特征和 CTC：B 细胞簇与继发性肝转移相关：黑色素瘤脑-肝转移轴

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma

免疫细胞因子 Simlukafusp Alfa (FAP-IL2v) 联合 Pembrolizumab 治疗晚期和/或转移性黑色素瘤的 Ib 期研究

PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

PARP 抑制剂对高级别浆液性输卵管卵巢癌不同遗传背景下的免疫反应进行差异调节